The aim of this study was to evaluate the diagnostic utility of sHLA-G as a tumor marker in comparison to the conventionally used cancer antigen (CA) 15-3 and carcinoembryonic antigen (CEA) markers in breast cancer. Here, CEACAM5 is linked to neoplasm.